Remove 2030 Remove Communication Remove Documentation
article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. billion Global concerns surrounding PFAS, or per- and polyfluoroalkyl substances, are due to their well-documented effects on human health and the environment. There is worldwide concern around the use of PFAS.

article thumbnail

Top 10 RPM Vendors 2025: Driving Results in Remote Patient Monitoring

PharmD Live

RPM investments projected to exceed $29 billion by 2030 , healthcare executives are demanding clinically validated solutions that streamline billing and maintain unwavering CMS alignment. Is your Remote Patient Monitoring (RPM) program delivering measurable clinical outcomes, audit-ready compliance, and scalable ROI?

HIPAA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The rise and rise of ESG in the pharmaceutical sector – is a zero-waste supply?chain possible?? 

Pharmaceutical Technology

AstraZeneca has announced its supply chain will be carbon negative by 2030. Automation via the company’s Aurora Platform has already resulted in significant time reductions – a 95% drop in manual evaluations for release documentation and a 97% overall decrease in time from delivery to release recommendation.

article thumbnail

Sustainability: Corporate Ambition, Governance, & Accelerated Delivery

ISPE

Transforming Our World: The 2030 Agenda for Sustainable Development.” a time horizon of 2030 is much more engaging than 2050). Communicating keynote successes will help encourage engagement and support. You may unsubscribe from these ISPE communications at any time. 1 United Nations. October 2015. link] 2 United Nations.

article thumbnail

A New Regulatory Approach to Drive Sustainable Medicines

ISPE

According to the proposal, all packaging shall be designed for recycling by 1 January 2030 and be recycled at scale by 1 January 2035. Guideline on the Requirements to the Chemical and Pharmaceutical Quality Documentation Concerning Investigational Medicinal Products in Clinical Trials.” Press Release. 30 November 2022.

article thumbnail

Cell and gene therapy: The vital role of logistics

Pharmaceutical Technology

The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn. of the global sales total.

article thumbnail

Environmental Sustainability in Biopharmaceutical Facility Design

ISPE

Transforming Our World: The 2030 Agenda for Sustainable Development.” There is an increase in those issuing a path to net zero design strategy document, which sets out design parameters covering all aspects of a project from initial concept through the commissioning, post-occupancy surveys, and audits. Accessed 3 December 2022.